Double Medical Technology Inc. (SHE:002901)
China
· Delayed Price · Currency is CNY 42.31
+0.58 (1.39%)
Apr 29, 2026, 3:04 PM CST
Double Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 599.63 | 356.8 | 58.96 | 92.56 | 673.31 | Upgrade
|
| Depreciation & Amortization | 134.49 | 125.61 | 111.9 | 95.51 | 70.85 | Upgrade
|
| Other Amortization | 106.7 | 96.57 | 82.49 | 42 | 11.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.62 | -0.27 | -0.3 | 1.73 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 6.26 | 0.93 | 0.88 | 1.91 | 0.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | -54.13 | -20.39 | -15.35 | -17.98 | -21.41 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.19 | 6.02 | -1.13 | -2.07 | 16.24 | Upgrade
|
| Other Operating Activities | 71.34 | 64.83 | 57.46 | 4.52 | 18.43 | Upgrade
|
| Change in Accounts Receivable | -58.54 | 4.64 | 86.8 | 121.91 | -179.38 | Upgrade
|
| Change in Inventory | -109.47 | -220.53 | -422.18 | -418.26 | -140.44 | Upgrade
|
| Change in Accounts Payable | 88.78 | 26.68 | 118.18 | 103.13 | 189.28 | Upgrade
|
| Change in Other Net Operating Assets | 43.66 | 7.87 | - | 105.55 | 38.08 | Upgrade
|
| Operating Cash Flow | 831.34 | 442.3 | 73.89 | 128.44 | 673.26 | Upgrade
|
| Operating Cash Flow Growth | 87.96% | 498.58% | -42.47% | -80.92% | 21.14% | Upgrade
|
| Capital Expenditures | -133.51 | -270.46 | -305.72 | -285.07 | -235.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.3 | 1.37 | 1.59 | 0.44 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | 1.66 | -88.02 | Upgrade
|
| Divestitures | -0.06 | - | - | - | - | Upgrade
|
| Investment in Securities | -543.27 | 406.86 | -213.77 | 40.75 | -96.03 | Upgrade
|
| Other Investing Activities | -2.66 | 13.75 | 9.89 | 16.74 | 22.59 | Upgrade
|
| Investing Cash Flow | -679.66 | 153.6 | -508.01 | -225.61 | -396.76 | Upgrade
|
| Long-Term Debt Issued | 94.87 | 159.05 | 532.61 | 50.77 | 1.11 | Upgrade
|
| Total Debt Issued | 94.87 | 159.05 | 532.61 | 50.77 | 1.11 | Upgrade
|
| Long-Term Debt Repaid | -178.15 | -377.83 | -12.33 | -11.36 | -8.33 | Upgrade
|
| Total Debt Repaid | -178.15 | -377.83 | -12.33 | -11.36 | -8.33 | Upgrade
|
| Net Debt Issued (Repaid) | -83.28 | -218.78 | 520.28 | 39.41 | -7.22 | Upgrade
|
| Issuance of Common Stock | 50.43 | - | - | 488.32 | 79.34 | Upgrade
|
| Repurchase of Common Stock | - | -234.98 | - | -75.68 | -2.92 | Upgrade
|
| Common Dividends Paid | -214.36 | -118.07 | -9.43 | -209.38 | -324.11 | Upgrade
|
| Other Financing Activities | -26.7 | -45.37 | -14.65 | 2.5 | -4.42 | Upgrade
|
| Financing Cash Flow | -273.91 | -617.2 | 496.2 | 245.16 | -259.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.71 | -11.37 | 1.06 | 4.31 | -3.55 | Upgrade
|
| Net Cash Flow | -116.52 | -32.68 | 63.14 | 152.3 | 13.61 | Upgrade
|
| Free Cash Flow | 697.83 | 171.84 | -231.82 | -156.63 | 438.15 | Upgrade
|
| Free Cash Flow Growth | 306.09% | - | - | - | 4.66% | Upgrade
|
| Free Cash Flow Margin | 26.83% | 8.05% | -15.12% | -10.92% | 21.97% | Upgrade
|
| Free Cash Flow Per Share | 1.71 | 0.41 | -0.55 | -0.37 | 1.09 | Upgrade
|
| Cash Income Tax Paid | 329.28 | 175.28 | 106.5 | 210.18 | 310.97 | Upgrade
|
| Levered Free Cash Flow | 539.67 | 72.26 | -105.63 | -240.44 | 303.33 | Upgrade
|
| Unlevered Free Cash Flow | 543.53 | 76.31 | -101.16 | -238.5 | 303.68 | Upgrade
|
| Change in Working Capital | -33.52 | -187.8 | -221.01 | -89.74 | -96.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.